Fady Ibraham Malik, Executive Vice President, Research & Development, on July 21, 2026, sold 3,500 shares in Cytokinetics (CYTK) for $282,065. Following the Form 4 filing with the SEC, Malik has control over a total of 153,902 common shares of the company, with 153,902 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1061983/000106198326000084/xslF345X05/form4.xml
Andrew J Briggs, Director, on July 20, 2026, sold 9,000 shares in Farmers & Merchants Bancorp (FMAO) for $276,180. Following the Form 4 filing with the SEC, Briggs has control over a total of 105,550 common shares of the company, with 105,550 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/792966/000119312526312607/xslF345X05/ownership.xml
Stephen L Philipson, Vice Chair, on July 20, 2026, sold 36,906 shares in US Bancorp (USB) for $2,327,920. Following the Form 4 filing with the SEC, Philipson has control over a total of 75,478 common shares of the company, with 74,969 shares held directly and 509 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/36104/000122520826006705/xslF345X05/doc4.xml
D James Bidzos, Director, Executive Chairman, President, & CEO, on July 21, 2026, sold 3,300 shares in Verisign (VRSN) for $892,466. Following the Form 4 filing with the SEC, Bidzos has control over a total of 416,239 common shares of the company, with 416,239 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1014473/000120481626000026/xslF345X05/wk-form4_1784752860.xml